Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Small Cell Lung Cancer Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchNot Yet RecruitingNCT07498439
What this trial is testing

TILs Therapy for Multiple Primary Early-Stage NSCLC

Who this might be right for
Primary Early-stage Non-small Cell Lung Cancer
Tianjin Medical University General Hospital 50
Testing effectiveness (Phase 2)UnknownNCT02758587
What this trial is testing

Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)

Who this might be right for
Carcinoma, Non-small-cell LungMesotheliomaPancreatic Neoplasms
NHS Greater Glasgow and Clyde 59
Testing effectiveness (Phase 2)Study completedNCT03304093
What this trial is testing

Immunotherapy by Nivolumab for HIV+ Patients

Who this might be right for
Non Small Cell Lung Cancer MetastaticNon Small Cell Lung Cancer Stage IIIBHIV/AIDS
Intergroupe Francophone de Cancerologie Thoracique 30
Early research (Phase 1)Study completedNCT03156114
What this trial is testing

This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.

Who this might be right for
NeoplasmsCarcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 172
Early research (Phase 1)Study completedNCT00006457
What this trial is testing

Oltipraz in the Prevention of Lung Cancer in People Who Smoke

Who this might be right for
Lung Cancer
Northwestern University
Testing effectiveness (Phase 2)WithdrawnNCT00998101
What this trial is testing

Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy

Who this might be right for
Lung Cancer
UNC Lineberger Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01362400
What this trial is testing

Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Infinity Pharmaceuticals, Inc. 226
Not applicableStudy completedNCT00732563
What this trial is testing

Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery

Who this might be right for
Lung Cancer
Roswell Park Cancer Institute 100
Early research (Phase 1)Ended earlyNCT01411098
What this trial is testing

Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIB Non-small Cell Lung CancerStage IIIA Non-small Cell Lung Cancer+1 more
University of Washington 6
Early research (Phase 1)Not Yet RecruitingNCT07110363
What this trial is testing

A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer

Who this might be right for
Advanced Malignant Solid TumorAdvanced Lung CancerNon-Small Cell Lung Cancer+1 more
Biotroy Therapeutics 58
Early research (Phase 1)Ended earlyNCT02400814
What this trial is testing

MPDL3280A and Stereotactic Ablative Radiotherapy in Patients With Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
Megan Daly, MD 27
Early research (Phase 1)Study completedNCT00252798
What this trial is testing

ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Carcinoma
AstraZeneca 44
Early research (Phase 1)Ended earlyNCT03948763
What this trial is testing

MRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)

Who this might be right for
NeoplasmsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms+1 more
Merck Sharp & Dohme LLC 70
Early research (Phase 1)Study completedNCT04204473
What this trial is testing

TY-9591 in Advanced Non-small Cell Lung Cancer(NSCLC) Patients With EGFR Positive Mutation

Who this might be right for
NSCLC
TYK Medicines, Inc 105
Large-scale testing (Phase 3)Looking for participantsNCT06345729
What this trial is testing

Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 600
Large-scale testing (Phase 3)Looking for participantsNCT06838273
What this trial is testing

BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line Treatment in Patients With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer(PANKU-Lung04)

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 720
Testing effectiveness (Phase 2)Study completedNCT01951586
What this trial is testing

Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Amgen 226
Not applicableWithdrawnNCT00530205
What this trial is testing

Effects of Radiation Therapy on the Body in Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMalnutritionWeight Changes
Case Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT02346370
What this trial is testing

A Phase 1b Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined With Docetaxel in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Halozyme Therapeutics 16
Large-scale testing (Phase 3)Ended earlyNCT03447769
What this trial is testing

Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A

Who this might be right for
Non-Small Cell Lung Cancer
Novartis Pharmaceuticals 1,382
Next Page